| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 01/03/2013 | US20130004514 Therapeutic antibodies |
| 01/03/2013 | US20130004507 METHODS OF ADMINISTERING ANTI-TNFalpha ANTIBODIES |
| 01/03/2013 | US20130004506 Method for treating pathologies associated with hypoxia using mif inhibitors |
| 01/03/2013 | US20130004495 Anti-ngf antibodies for the treatment of various disorders |
| 01/03/2013 | US20130004491 Antibodies Against Phosphorylcholine In Combination Therapy with Biologic Agents |
| 01/03/2013 | US20130004490 Delivery of transthyretin across the blood-brain barrier as a treatment for alzheimer's disease |
| 01/03/2013 | US20130004471 Gene therapy vectors for adrenoleukodystrophy and adrenomyeloneuropathy |
| 01/03/2013 | US20130004467 Myelination of congenitally dysmyelinated forebrains using oligodendrocyte progenitor cells |
| 01/03/2013 | US20130004465 Adherent cells from placenta and use of same in disease treatment |
| 01/03/2013 | US20130004464 Multipotent adult stem cell population |
| 01/03/2013 | US20130004431 Transport agents for crossing the blood-brain barrier and into brain cancer cells and methods of use thereof |
| 01/03/2013 | US20130004428 Diazabicyclononyl oxadiazole compounds and their use as nicotinic acetylcholine receptor modulators |
| 01/03/2013 | US20130004422 Benzothiazole derivative compounds, compositions and uses |
| 01/03/2013 | US20130004416 Dual Variable Domain Immunoglobulin and Uses Thereof |
| 01/03/2013 | CA2840643A1 Peripherally acting opioid compounds |
| 01/03/2013 | CA2840577A1 Soluble integrin .alpha.4 mutant |
| 01/03/2013 | CA2840574A1 Method for producing fine particles of aripiprazole anhydride crystals b |
| 01/03/2013 | CA2838976A1 Dha and epa in the reduction of oxidative stress |
| 01/03/2013 | CA2838645A1 1-aryl-4-methyl-[1,2,4]triazolo[4,3-a]quinoxaline derivatives |
| 01/03/2013 | CA2838495A1 Substituted cinnamamide derivative, preparation method and use thereof |
| 01/03/2013 | CA2838321A1 Sulphonamide derivatives of alicyclic amines for the treatment of the central nervous system diseases |
| 01/03/2013 | CA2837453A1 Crystals of glycine derivative and pharmaceutical use thereof |
| 01/03/2013 | CA2833824A1 Fluorinated arylalkylaminocarboxamide derivatives |
| 01/03/2013 | CA2831154A1 Use of pertussis toxin as a therapeutic agent |
| 01/02/2013 | EP2540722A1 Novel anxiolytic compounds |
| 01/02/2013 | EP2540308A1 Therapeutic agent for eating disorders |
| 01/02/2013 | EP2540295A1 Compositions for the treatment of Fragile X syndrome |
| 01/02/2013 | EP2540292A1 DHA and EPA in the reduction of oxidative stress |
| 01/02/2013 | EP2539857A2 Crystalline forms of the tri-mesylate salt of perphenazine-gaba and process of producing the same |
| 01/02/2013 | EP2539706A1 Arylpiperazone opioid receptor antagonists |
| 01/02/2013 | EP2539346A1 Heterocycloalkyl-containing thienopyrimidines for pharmaceutical compositions |
| 01/02/2013 | EP2539345A1 4 - [cycloalkyloxy (hetero) arylamino]thieno [2, 3 - d]pyrimidines having mnkl/ mnk2 inhibiting activity for pharmaceutical compositions |
| 01/02/2013 | EP2539344A1 Halogen or cyano substituted thieno [2,3-d]pyrimidines having mnk1/mnk2 inhibiting activity for pharmaceutical compositions |
| 01/02/2013 | EP2539342A1 Pyrazolopyrimidine compounds and their use as pde10 inhibitors |
| 01/02/2013 | EP2539322A1 Inhibitors of beta-secretase |
| 01/02/2013 | EP2539313A2 Crystal forms of o-desmethylvenlafaxine fumarate |
| 01/02/2013 | EP2538939A1 Prevention and treatment of diseases caused by elevated levels of deoxy-sphingolipids |
| 01/02/2013 | EP2538919A2 Pharmaceutical compositions of spiro-oxindole compound for topical administration and their use as therapeutic agents |
| 01/02/2013 | EP2538779A1 Diversion-and/or abuse-resistant compositions and methods for making the same |
| 01/02/2013 | EP2182949B1 (2s,3r)-n-(2-((3-pyridinyl)methyl)-1-azabicyclo[2.2.2]oct-3-yl)benzofuran-2-carboxamide, novel salt forms, and methods of use thereof |
| 01/02/2013 | CN1674934B Vaccine compositions containing amyloid beta1-6 antigen arrays |
| 01/02/2013 | CN1454215B Antigen-binding fragments specific for dendritic cells, compositions and methods of use thereof antigens recognized thereby and cells obtained thereby |
| 01/02/2013 | CN102858796A Oligomer-specific amyloid beta epitope and antibodies |
| 01/02/2013 | CN102858782A 4 - [cycloalkyloxy (hetero) arylamino] thieno [2, 3 - d] pyrimidines having mnkl/ mnk2 inhibiting activity for pharmaceutical compositions |
| 01/02/2013 | CN102858778A Heterobiaryl-cyclohexyl-tetraazabenzo[e]azulenes |
| 01/02/2013 | CN102858775A Pyrrazolopyridine derivatives |
| 01/02/2013 | CN102858772A Imidazo[1,2-a]pyridine derivative |
| 01/02/2013 | CN102858769A Pyrazolopyridine kinase inhibitors |
| 01/02/2013 | CN102858766A Polymorphs of a metabotropic glutamate receptor positive allosteric modulator |
| 01/02/2013 | CN102858763A Prolylhydroxylase inhibitors and methods of use |
| 01/02/2013 | CN102858760A Glycine chroman-6-sulfonamides for use as inhibitors of diacylglycerol lipase |
| 01/02/2013 | CN102858753A Glycine chroman-6-sulfonamides for use as inhibitors of diacylglycerol lipase |
| 01/02/2013 | CN102858748A Therapeutic agent and preventative agent for Alzheimer's disease |
| 01/02/2013 | CN102858371A Antigen Binding Proteins Specific For Serum Amyloid P Component |
| 01/02/2013 | CN102858355A Expression Modulator For Clock Gene Bmal |
| 01/02/2013 | CN102858349A Pharmaceutical Composition For The Treatment Of Alzheimer's Disease, Method For Producing Same And Use Thereof |
| 01/02/2013 | CN102858342A Arylvinylazacycloalkane compounds for constipation |
| 01/02/2013 | CN102858340A Prophylactic or therapeutic agent for diseases associated with pains in urinary organs |
| 01/02/2013 | CN102858339A Combination of a serotonin and norepinephrine reuptake inhibitor and an opioid agonist for the treatment of pain |
| 01/02/2013 | CN102858331A Pharmaceutical compositions and therapeutic applications of a hydrocortisone derivative designated as deina |
| 01/02/2013 | CN102858329A Compounds for use in the treatment of diseases |
| 01/02/2013 | CN102851183A Ophiopogon japonicus health wine with effects of removing heart-fire and relieving restlessness |
| 01/02/2013 | CN102850431A Chimeric peptide based on opioid peptide Biphalin and neuropeptide FF, its synthesis and application |
| 01/02/2013 | CN102850424A 3-Hydroxyprogesterone-21-(2',5'-dimethoxy)benzylidene-5-ene-20-one and preparation method and application thereof |
| 01/02/2013 | CN102850403A Water-soluble iron carbonyl compound, and preparation method and application thereof |
| 01/02/2013 | CN102850349A Fused, tricyclic sulfonamide inhibitors of gamma secretase |
| 01/02/2013 | CN102850336A Derivatives of 4-piperazin-1-yl-4-benz0 [b] thiophene suitable for the treatment of cns disorders |
| 01/02/2013 | CN102850335A Optical isomers and pharmaceutical application thereof |
| 01/02/2013 | CN102850324A Indole compounds |
| 01/02/2013 | CN102850318A Novel selective 5-serotonin reuptake inhibitor and its medical use |
| 01/02/2013 | CN102850317A Substituted cinnamide derivative, its preparation method and application |
| 01/02/2013 | CN102850268A Aripiprazole I-type crystallite, aripiprazole solid preparation and preparation methods thereof |
| 01/02/2013 | CN102850236A Novel benzamide histone deacetylase inhibitor and application thereof |
| 01/02/2013 | CN102847164A Application of chrysalis oil in improving small molecule drug bioavailability |
| 01/02/2013 | CN102847154A Therapeutic uses of inhibitors of RTP801 |
| 01/02/2013 | CN102847139A Applications of basic fibroblast growth factor in preparation of drugs for treatment of spinal cord injuries |
| 01/02/2013 | CN102847138A Medicine composition containing muscular amino acid and nucleoside compound and preparation method thereof |
| 01/02/2013 | CN102847136A Composition for enzyme inhibition |
| 01/02/2013 | CN102847129A Prepared rhizome of rehmannia qi-blood tonifying tablets |
| 01/02/2013 | CN102847126A Deer-horn glue qi-blood tonifying tablets |
| 01/02/2013 | CN102847120A Group of paralysis pain capsules containing American ginsengs, coptis chinensis and asarum |
| 01/02/2013 | CN102847111A Tongli heat purging capsule |
| 01/02/2013 | CN102847099A Blood-replenishing spleen-strengthening tablet |
| 01/02/2013 | CN102847092A Preparation process of integration-type novel formulation of Evodia rutaecarpa decoction and production method thereof |
| 01/02/2013 | CN102847083A A Chinese medicinal powder for treating epilepsy |
| 01/02/2013 | CN102847075A Medicine composition for treating insomnia |
| 01/02/2013 | CN102847070A Sandalwood pain killer by promoting circulation of qi |
| 01/02/2013 | CN102847069A Traditional Chinese drug composition for treating angioneurotic headache |
| 01/02/2013 | CN102847063A Traditional Chinese medicinal composition for treating qi and blood deficiency blood stasis type diabetic feet, and its preparation method |
| 01/02/2013 | CN102847050A A Chinese medicinal effective fraction composition for treating depression |
| 01/02/2013 | CN102847044A Hypnotic |
| 01/02/2013 | CN102847041A A Chinese medicinal formulation for treating puerperal depression |
| 01/02/2013 | CN102847035A A Chinese medicinal formulation for treating tuberculous meningitis |
| 01/02/2013 | CN102847034A Combined spicebush root shrinkage spring tablet group |
| 01/02/2013 | CN102847022A Traditional Chinese medicine preparation used for preventing and treating aluminum-induced senile dementia |
| 01/02/2013 | CN102846993A Externally-used plaster for treating infantile febrile convulsion |
| 01/02/2013 | CN102846990A Stomach invigorating pills |
| 01/02/2013 | CN102846989A Tablets with functions of liver cooling and body fluid increasing |
| 01/02/2013 | CN102846988A Composition tablet for cooling the liver to extinguish wind |
| 01/02/2013 | CN102846984A Preparation process and production method for Cornu Saigae Tataricae and Ramulus Uncariae Cum Uncis Decoction preparation in an integrated new dosage form |